Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Differential expression profiles of RNAs in Hep3B cells treated with Bufotalin

ABSTRACT: Differential expression profiles of RNAs in Hep3B cells treated with Bufotalin

PROVIDER: PRJNA1143374 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Differential expression profiles of RNAs in Hep3B cells treated with Bufotalin

Project description:We extracted the total RNA of Hep3B cells treated with Bufotalin for 48 h and used RNA-seq technology to detect differentially expressed RNAs such as lncRNAs, miRNAs, and mRNAs in Hep3B cells.

2025-08-10 | GSE273801 | GEO

Differential expression profiles of RNAs in Hep3B cells after silencing LINC01547

Project description:Differential expression profiles of RNAs in Hep3B cells after silencing LINC01547

| PRJNA1143373 | ENA

Differential expression profiles of RNAs in Hep3B cells after silencing LINC01547

Project description:We extracted the total RNA of Hep3B cells after silencing LINC01547 for 48 h and used RNA-seq technology to detect differentially expressed RNAs in Hep3B cells.

2025-08-10 | GSE273802 | GEO

Differential gene expression in Hep3B and Hep3B SOX4-/- cells

Project description:Overexpression of SOX4 in various kinds of cancers specimen was associated with poor prognosis of patients; however, the role of SOX4 in angiogenesis or tumor microenvironment modulation remains unclear. Therefore the endogenous SOX4 was knockout and the differential gene expression between Hep3B and Hep3B SOX4-/- cells were examined via genechip. We found that the differentially expressed genes, EzH2, a SOX4-associated partner, and CXCL12, were repressed in Hep3B SOX4-/- cells compared with parental Hep3B; these results were further assessed via qRT-PCR in Hep3B SOX4-/- versus Hep3B cells.

2020-12-01 | GSE141909 | GEO

Differential gene expression in Hep3B and Hep3B SOX4-/- cells

Project description:Differential gene expression in Hep3B and Hep3B SOX4-/- cells

| PRJNA595153 | ENA

Differential expression profiles of RNAs in mouse melanoma cells treated with ATRA and PB-4

Project description:Differential expression profiles of RNAs in mouse melanoma cells treated with ATRA and PB-4

| PRJNA749047 | ENA

Gene expression profiles of ATO-treated and negative control cells

Project description:Gene expression profile changes between ATO- treated and DMSO- treated Huh7 and Hep3B cells were analyzed To further explore the mechanism of ATO-induced differentiation, we performed a gene microarray assay to compare the differential gene expression profiles of low-dose ATO-treated (3 μM ATO treatment for 7 days) and negative control cells.

2019-07-01 | GSE128517 | GEO

Human liver cancer cells Hep3B: Valeric acid treated vs. Control

Project description:Transcriptional profiling of human liver cancer cells (Hep3B) treated with valeric acid compared to control.

2021-11-12 | GSE140280 | GEO

Differential mRNA expression profile regulated by HNF4α in Hep3B cells

Project description:A previous study from this laboratory demonstrated that up-regulating HNF4a could reverse the malignant phenotypes of HCC by inducing redifferentiation of HCC cells to hepatocytes. To study the mechanisms of the hepatic differentiation effect by HNF4α, we used the cDNA microarray to detect differential gene expression profiles of Hep3B infected with AdHNF4α and AdGFP. Expression profile analysis revealed that HNF4α positively regulated 1218 mRNAs and negatively regulated 1411 mRNAs for more than 2 times. The pathway analysis for the differential genes showed that the genes were involved in Complement and coagulation cascades, metabolism, Type II diabetes mellitus, Pathways in cancer etc.

2015-06-01 | GSE66785 | GEO

Differential expression profiles of RNAs in mouse melanoma cells treated with ATRA and PB-4

Project description:We extracted the total RNA of B16 cells treated with ATRA or PB-4 for 48 h and used RNA-seq technology to detect differentially expressed RNAs such as lncRNAs, miRNAs, and mRNAs in B16 cells. The results showed that compared with the normal control group, 102 lncRNAs, 24 miRNAs, and 761 mRNAs showed differential expression in the ATRA-treated group, and 306 lncRNAs, 105 miRNAs, and 2567 mRNAs showed differential expression in the PB-4-treated group.

2021-07-24 | GSE180667 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data